The Calypso System, with its GPS for the Body technology, utilises implanted Beacon transponders to provide precise, continuous information on the location of the tumor during external beam
Using its proprietary ProMIS computational platform discovery technology, Amorfix has identified several disease specific epitopes (DSEs) on misfolded Fas receptor. Aragen is expected to use those DSEs to
ABI claimed that by taking Maxisal, cancer patients may be able to relieve at least one of the side effects of cancer therapy, dry mouth. Maxisal was first
CrystalGenomics said that the main motive for this merger is to provide necessary tools and infrastructure for CrystalGenomics to transform into a intergrated BioPharmaceutical company with discovery, development
As per the expanded agreement, Restanza’s in-vitro activity against Neisseria gonorrhoeae and other key STI’s is expected to be assessed, to advance Restanza into clinical development in government-sponsored
Huya said that the agreement with the School of Chinese Materia Medica of BUCM provides it with access to and first review of certain new therapeutic candidates owned
The study showed that infants fed with Enfamil Lipil containing DHA and ARA during the first year of life experienced improved immune outcomes, including improved respiratory health, versus
GeoVax Labs claimed that although the company’s vaccines are currently being studied for HIV prevention, this is the first study using the same products for treatment of persons
The first team of investigators is from the University of Texas Health Sciences Center at Houston, while members from the University of Washington and Pacific Northwest National Laboratory
Vertex has added that 69% of people achieved SVR after receiving an 8-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone. 44% of people in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.